Title:
【発明の名称】IL―8レセプターアンタゴニスト
Document Type and Number:
Japanese Patent JP2001527519
Kind Code:
A
Abstract:
This invention relates to the use of compounds of formula (I) in the treatment of disease states mediated by the chemokine, Interleukin-8 (IL-8). The variables of (I) are defined herein.
More Like This:
| JP2009051748 | METHOD FOR PRODUCING SEAMLESS CAPSULE |
| WO/1995/008997 | RANITIDINE AND CALCIUM CARBONATE PHARMACEUTICAL COMBINATION PRODUCT |
| JPH09194365 | ACTIVE OXYGEN SUPPRESSANT |
Inventors:
Brian, Deborah Lin
Gleason, John Gerald
Catherine Elle, Widson
Gleason, John Gerald
Catherine Elle, Widson
Application Number:
JP51011798A
Publication Date:
December 25, 2001
Filing Date:
August 15, 1997
Export Citation:
Assignee:
SMITHKLINE BEECHAM CORPORATION
International Classes:
A61P1/04; A61K31/155; A61P7/02; A61P9/02; A61P9/10; A61P11/00; A61P11/06; A61P13/12; A61P17/00; A61P17/06; A61P19/02; A61P25/28; A61P37/06; C07C279/18; C07C279/22; C07C279/24; C07C279/28; C07C335/16; (IPC1-7): C07C279/18; A61K31/155; A61P1/04; A61P7/02; A61P9/02; A61P9/10; A61P11/00; A61P11/06; A61P13/12; A61P17/00; A61P17/06; A61P19/02; A61P25/28; A61P37/06; C07C279/22; C07C279/24; C07C279/28
Attorney, Agent or Firm:
Aoyama Ryo (1 person outside)